Quotes Denali Therapeutics Inc. Sao Paulo
Stocks
D2NL34
BRD2NLBDR008
Biotechnology & Medical Research
|
Market Closed -
Sao Paulo
14:04:39 2026-07-13 EDT
|
5-day change | 1st Jan Change | ||
| 27.06 BRL | -1.31% |
|
-.--% | +25.57% |
| 08-25 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
Stock exchange
Sao Paulo
D2NL34 27.06 R$
-1.31%
54.12
R$
Performance
| 1 day | -1.31% | ||
| 3 months | +31.61% | ||
| 6 months | +21.95% | ||
| Current year | +25.57% | ||
| 1 year | +63.41% | ||
| 3 years | -28.34% |
Volumes
marketsDaily volume
2
Estimated daily volume
2
Record volume 1
16,900
Record volume 2
16,900
Record volume 3
1,406
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (BRL)
3,797,974,295
Market Cap (USD)
3,797,974,295
Net sales (USD)
0
Number of employees
503
Sales / Employee (USD)
0
Free-Float
90.03 %
Free-Float capitalization (BRL)
664,361,005
Free-Float capitalization (USD)
3,419,466,090
Indicators
Moving average 5 days
27.21
Moving average 20 days
22.68
Moving average 50 days
13.28
Moving average 100 days
22.86
Price spread / (MMA5)
+0.55%
Price spread / (MMA20)
-16.20%
Price spread / (MMA50)
-50.91%
Price spread / (MMA100)
-15.54%
STIM
RSI 9 days
68.58
RSI 14 days
68.59
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.31% | -.--% | +63.41% | -28.34% | 3.8B | ||
| -0.25% | -0.92% | +49.47% | +89.45% | 68.13B | ||
| +1.21% | +0.80% | +46.29% | +85.32% | 63.6B | ||
| +1.31% | -5.21% | +37.52% | +12.07% | 25.57B | ||
| -0.25% | -1.92% | -10.72% | +436.70% | 26.6B | ||
| +0.33% | -10.61% | +1.95% | -16.27% | 25.52B | ||
| -6.09% | -12.08% | +226.11% | +375.00% | 18.23B | ||
| +1.18% | -2.23% | +30.87% | -19.04% | 19.69B | ||
| -1.49% | -6.44% | +0.78% | +540.26% | 15.16B | ||
| +4.12% | +0.30% | +52.03% | +150.18% | 13.54B | ||
| Average | -0.12% | -3.85% | +49.77% | +162.53% | 27.98B | |
| Weighted average by Cap. | +0.13% | -2.88% | +45.47% | +141.54% |
Historical Quotes: Denali Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| Current year | 19.44 | 27.42 | |
| 1 year | 13.5 | 27.42 | |
| 3 years | 13.48 | 36.2 | |
| 5 years | 13.48 | 40.04 | |
| 10 years | 13.48 | 40.04 |
Monthly variations
Annual variations
| 2026 | +25.57% | ||
| 2025 | -24.09% | ||
| 2024 | -24.81% | ||
| 2022 | +1.27% |
- Stock Market
- Stocks
- DNLI Stock
- D2NL34 Stock
- Quotes Denali Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions

















